Cynata Therapeutics Limited's market cap is currently ―. The company's EPS TTM is AU$-0.087; its P/E ratio is -2.40; Cynata Therapeutics Limited is scheduled to report earnings on August 22, 2024, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 22	Jun 21	Jun 20	Jun 19	Jun 18
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	AU$ 23.80M	AU$ 26.72M	AU$ 13.65M	AU$ 6.98M	AU$ 12.21M
Total Assets	AU$ 26.55M	AU$ 29.97M	AU$ 17.48M	AU$ 12.25M	AU$ 16.13M
Total Debt	AU$ 0.00	AU$ 0.00	AU$ 0.00	AU$ 0.00	AU$ 0.00
Net Debt	AU$ -23.80M	AU$ -26.72M	AU$ -13.65M	AU$ -6.98M	AU$ -12.21M
Total Liabilities	AU$ 2.59M	AU$ 1.60M	AU$ 689.74K	AU$ 1.28M	AU$ 746.15K
Stockholders Equity	AU$ 23.96M	AU$ 28.37M	AU$ 16.79M	AU$ 10.97M	AU$ 15.39M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in AUD

Cynata Therapeutics Limited Earnings and Revenue History

Income Statement >

Cynata Therapeutics Limited Debt to Assets

Balance Sheet >

Cynata Therapeutics Limited Cash Flow

Cash Flow >

Cynata Therapeutics Limited Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing